TKT Hemophilia Gene Therapy Trial Halted Despite No Evidence Of Problems
Executive Summary
The suspension of Transkaryotic Therapies' gene therapy trial at Beth Israel Deaconess Medical Center could signal the beginning of a trend of gene therapy trial suspensions as a cautionary measure even if the study shows no sign of problems.